The weekly litigation news digest is live. Subscribe now

Nucleoside Derivatives As Inhibitors Of Rna-Dependent Rna Viral Polymerase

Patent No. EP2399588 (titled "Nucleoside Derivatives As Inhibitors Of Rna-Dependent Rna Viral Polymerase") was filed by Ionis Pharmaceuticals on Jan 18, 2002. The application was issued on Apr 29, 2020.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
GILEAD SCIENCESJan 7, 2021J A KEMP

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2399588

IONIS PHARMACEUTICALS
Application Number
EP11178613A
Filing Date
Jan 18, 2002
Status
Revoked
Nov 18, 2022
Publication Date
Apr 29, 2020